Theagene Jean-Manasse 4
4 · MAIA Biotechnology, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2023-09-30+8,378→ 8,378 totalExercise: $2.20From: 2023-09-30Exp: 2033-09-30→ Common Stock (8,378 underlying)
Footnotes (1)
- [F1]The stock options, granted on September 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.